DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bjzpcv/tumor_ablation) has announced the addition of the "Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecasts to 2020" report to their offering.
In this report, the global tumor ablation market is segmented on the basis of technology (radiofrequency ablation, microwave ablation, cryoablation, and other technologies), mode of treatment (surgical, laparoscopic, and percutaneous ablation), and application (liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications). The radiofrequency ablation technology segment accounted for the largest share of the global tumor ablation market in 2014, followed by the microwave ablation technology market
Growth in the tumor ablation market is driven by factors such as growing geriatric population across the world, increasing population base for cancer patients, technological advancements in ablation devices, increasing number of hospitals and surgical and ablation centers, and growing awareness regarding the benefits offered by ablation procedures over those of conventional therapeutic and surgical procedures.
However, factors such as cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are restraining the growth of this market. In addition, therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to significant increase in gestation period of product launches are posing significant challenges for the growth of the tumor ablation market.
Factors such as significant awareness in the medical community about the application of radiofrequency ablation in cancer treatments, presence of a large number of radiofrequency ablation centers across the globe, and low procedural costs associated with radiofrequency tumor ablation are driving the growth of the radiofrequency tumor ablation market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Tumor Ablation Market, By Technology
8 Tumor Ablation Market, By Mode of Treatment
9 Tumor Ablation Market, By Application
10 Tumor Ablation Market, By Region
11 Competitive Landscape
12 Company Profiles
- Angiodynamics, Inc.
- Boston Scientific Corporation
- EDAP TMS S.A.
- Galil Medical, Inc.
- Healthtronics, Inc.
- Medtronic, PLC.
- Mermaid Medical A/S
- Misonix, Inc.
- Neuwave Medical, Inc.
- Sonacare Medical, LLC
For more information visit http://www.researchandmarkets.com/research/bjzpcv/tumor_ablation